APA (7th ed.) Citation

Courtney A. Penn, Erica V. Carballo, Christine S. Walsh, Oliver Zivanovic, & Kenneth H. Kim. (2022). Cost-effectiveness of hyperthermic intraperitoneal chemotherapy at primary cytoreduction of epithelial ovarian cancer based on residual disease status. Elsevier.

Chicago Style (17th ed.) Citation

Courtney A. Penn, Erica V. Carballo, Christine S. Walsh, Oliver Zivanovic, and Kenneth H. Kim. Cost-effectiveness of Hyperthermic Intraperitoneal Chemotherapy at Primary Cytoreduction of Epithelial Ovarian Cancer Based on Residual Disease Status. Elsevier, 2022.

MLA (9th ed.) Citation

Courtney A. Penn, et al. Cost-effectiveness of Hyperthermic Intraperitoneal Chemotherapy at Primary Cytoreduction of Epithelial Ovarian Cancer Based on Residual Disease Status. Elsevier, 2022.